Brand name, compounded, insurance, telehealth — every option explained with real numbers
Cost is one of the biggest barriers to weight loss injections — and one of the most confusing aspects of the entire landscape. The price difference between the most expensive and least expensive options for the same medication can be $1,200 per month. Understanding the full picture helps people access these medications at a price that’s actually sustainable.
Here’s the complete, honest breakdown of what weight loss injections actually cost across every access pathway.
Brand Name Medication Prices (Without Insurance)
These are the retail prices for brand name medications at US pharmacies without insurance coverage — the headline numbers that make weight loss injections seem inaccessible to most people.
Wegovy (semaglutide 2.4mg — approved for weight loss):
- Approximately $1,300-1,500 per month
- 4 injections per pack (one per week)
- Annual cost without insurance: approximately $15,600-18,000
Ozempic (semaglutide — approved for diabetes, widely used off-label for weight loss):
- Approximately $900-1,000 per month at doses used for weight loss
- Annual cost without insurance: approximately $10,800-12,000
Zepbound (tirzepatide — approved for weight loss):
- Approximately $1,000-1,300 per month
- Annual cost without insurance: approximately $12,000-15,600
Mounjaro (tirzepatide — approved for diabetes, used off-label for weight loss):
- Approximately $900-1,100 per month
- Annual cost without insurance: approximately $10,800-13,200
Saxenda (liraglutide — approved for weight loss, daily injection):
- Approximately $1,300-1,500 per month
- Annual cost without insurance: approximately $15,600-18,000
These prices represent the ceiling — what you’d pay if you walked into a pharmacy with no insurance and no discount program. Most people access these medications for significantly less through the options below.
With Insurance Coverage
Insurance coverage for weight loss injections varies dramatically — and is one of the most frustrating aspects of the landscape.
What Insurance Typically Covers
Diabetes indication (Ozempic, Mounjaro, Victoza): Most insurance plans that cover GLP-1 medications cover them for type 2 diabetes management. With insurance, out-of-pocket costs for diabetes-indicated medications are typically:
- $25-100 per month copay with commercial insurance
- Varies significantly by plan
Weight loss indication (Wegovy, Zepbound, Saxenda): Coverage for weight loss specifically is inconsistent:
- Many commercial insurance plans do NOT cover weight loss medications
- Some employers have explicitly excluded weight loss medications from coverage
- Medicaid coverage varies by state
- Medicare Part D currently does not cover weight loss medications — this is a significant barrier for older adults
Checking Your Coverage
To determine your specific coverage:
- Call the member services number on your insurance card
- Ask specifically about coverage for the medication by name (Wegovy, Zepbound, etc.)
- Ask whether prior authorization is required
- Ask about your specific copay and deductible
Prior authorization is almost always required for weight loss medications even when covered — requiring documentation of BMI, qualifying conditions, and often previous failed attempts at weight loss through other means.
Manufacturer Savings Programs
Novo Nordisk (Wegovy) savings card: For commercially insured patients (not Medicare/Medicaid), Novo Nordisk offers savings cards that can reduce cost to approximately $0-25 per month for eligible patients — for a defined period (typically 12 months).
Eli Lilly (Zepbound) savings card: Similarly offers savings programs for commercially insured patients — potentially reducing cost to $25-50 per month.
Important: These savings programs are available to commercially insured patients only — not Medicare or Medicaid beneficiaries. And they have eligibility requirements and time limits.
Compounded Semaglutide and Tirzepatide — The Most Affordable Option
This is the option that has made weight loss injections accessible to millions of people who couldn’t afford brand name prices — and it requires careful explanation.
What Is Compounded Medication?
FDA-registered compounding pharmacies can legally produce custom medications when:
- The brand name medication is on the FDA drug shortage list, OR
- A patient has a medical need for a customized formulation
During the semaglutide and tirzepatide shortage periods (which began as demand dramatically exceeded supply), compounding pharmacies produced copies of these medications at dramatically lower prices.
Compounded Medication Prices
Compounded semaglutide:
- Approximately $150-400 per month through telehealth providers
- Annual cost: approximately $1,800-4,800
Compounded tirzepatide:
- Approximately $200-500 per month through telehealth providers
- Annual cost: approximately $2,400-6,000
The cost difference is dramatic — compounded semaglutide at $200/month vs. brand name Wegovy at $1,400/month represents a saving of $14,400 per year for the same active ingredient.
The Important Regulatory Caveat
The FDA has been actively addressing the compounded GLP-1 landscape:
- As drug shortages resolve, the FDA has taken action against compounded versions
- The regulatory status of compounded semaglutide and tirzepatide changes frequently
- Some compounders use slightly different salt forms (semaglutide sodium vs. semaglutide base) that add additional regulatory uncertainty
The practical reality: Compounded GLP-1 medications remain available through many telehealth providers at the time of writing — but the landscape is evolving. Discuss the current regulatory status with your prescriber.
Is Compounded as Effective as Brand Name?
The active ingredient is the same — semaglutide or tirzepatide. What differs:
- The excipients (inactive ingredients) may vary
- Quality control is regulated but different from FDA-approved manufacturing standards
- Formulation (concentration, pen device) may differ
Most people using compounded GLP-1 medications through reputable providers report equivalent results to brand name. However, “reputable provider” matters significantly — the compounded medication landscape includes both high-quality FDA-registered pharmacies and lower-quality operations.
Telehealth Providers — How They Change the Cost Equation
Telehealth has been the primary driver of accessibility for weight loss injections — both by providing access to compounded medications and by reducing the overhead costs of traditional in-person obesity medicine clinics.
What Telehealth Providers Typically Include
Most telehealth weight loss injection programs include:
- Online medical evaluation and consultation
- Prescription if medically appropriate
- Medication shipped to home (compounded or, in some cases, brand name)
- Ongoing provider support and dose management
- Regular check-ins
Telehealth Provider Price Range
Lower cost providers (compounded medication):
- $150-400 per month all-inclusive
- Example: Various telehealth platforms offering compounded semaglutide
Mid-range providers:
- $300-600 per month
- May include additional support services, nutrition coaching, or app-based monitoring
Higher cost providers (brand name medication assistance):
- $400-800+ per month
- Assist with insurance navigation and manufacturer savings programs for brand name medications
Gala offers telehealth evaluation and GLP-1 compounded medication access at competitive pricing — with licensed medical providers managing the entire process.
[Check pricing and eligibility at Gala →]
This is a paid partnership. Gala is a licensed telehealth provider. Medication is only prescribed following a medical consultation and is not guaranteed.
GoodRx and Pharmacy Discount Programs
For brand name medications, pharmacy discount programs like GoodRx can sometimes reduce cost:
GoodRx discounts on semaglutide/tirzepatide:
- Discounts are limited for these specific medications — typically 10-20% off retail
- Still leaves medications at $800-1,200/month range
- Less impactful than manufacturer savings cards or compounded alternatives
GoodRx is more useful for other aspects of weight loss medication management — such as metformin or other adjunct medications that may be prescribed alongside GLP-1 medications.
The True Long-Term Cost
A calculation that’s frequently missing from conversations about these medications:
If weight loss injections are a long-term or indefinite treatment (as the evidence suggests they are for most people — as covered in our guide to what happens when you stop weight loss injections) — the total lifetime cost is significant:
At compounded prices ($250/month):
- 1 year: $3,000
- 5 years: $15,000
- 10 years: $30,000
At brand name prices ($1,400/month):
- 1 year: $16,800
- 5 years: $84,000
- 10 years: $168,000
This long-term cost reality underscores why compounded options, insurance coverage, and employer benefits matter so much — and why the political and policy conversation around coverage for these medications is increasingly important.
Ways to Reduce Cost
1. Check Insurance Coverage First
Even if you expect it not to be covered — check. Coverage policies change frequently, and some employers have added coverage as these medications have become more mainstream.
2. Use Manufacturer Savings Programs
If you have commercial insurance (not Medicare/Medicaid), manufacturer savings cards can reduce cost to $0-50/month — making brand name medications genuinely affordable for a defined period.
3. Consider Telehealth + Compounded Medication
The most accessible price point for most people. Compounded semaglutide through a reputable telehealth provider at $200-400/month provides the active ingredient at a fraction of brand name cost.
4. Ask About Dose Adjustment for Cost Management
Some prescribers will maintain patients at a lower dose that produces meaningful results at lower cost than the maximum dose. Not all patients need the full 2.4mg semaglutide to achieve significant weight loss.
5. Explore Patient Assistance Programs
Pharmaceutical manufacturers offer patient assistance programs for people who meet income eligibility requirements. Novo Nordisk’s assistance program (NovoCare) provides medication at reduced or no cost for qualifying patients.
6. Employer Benefits
Some employers have specifically added GLP-1 medications to their benefits packages as evidence of their clinical value has accumulated. Check with your HR department about current coverage and upcoming benefits changes.
7. HSA/FSA Funds
Health Savings Account (HSA) and Flexible Spending Account (FSA) funds can typically be used for prescription medications — including weight loss injections when prescribed for an eligible medical condition. This provides a tax-advantaged way to pay for the medication.
Cost vs. Value — The Honest Calculation
The question of whether weight loss injections are “worth” the cost requires considering what obesity costs:
Direct healthcare costs of obesity:
- Type 2 diabetes management: $10,000-15,000+ per year
- Cardiovascular disease treatment: $20,000-50,000+ per year
- Sleep apnea treatment: $1,000-3,000+ per year
- Joint replacement surgery: $30,000-50,000+
- Ongoing medication for obesity-related conditions
The SELECT trial finding — that semaglutide reduced major cardiovascular events by 20% — suggests that for high-risk patients, the medication may actually reduce total healthcare costs over time by preventing expensive cardiovascular events.
Quality of life value: Improved mobility, reduced pain, better sleep, higher energy, and improved psychological wellbeing are real but harder to quantify in dollar terms.
For people with significant obesity-related health conditions — diabetes, cardiovascular disease, sleep apnea, joint pain — the cost of weight loss injections may be offset by reductions in other healthcare spending and improvement in quality of life.
The Cost Landscape Is Changing
The weight loss injection market is evolving rapidly in ways that are likely to reduce costs over time:
Patent expiration: Semaglutide patents begin expiring in the late 2020s — generic versions will eventually be available at dramatically lower prices, as has happened with every major medication class.
Oral formulations: Oral semaglutide (Rybelsus) is already FDA-approved for diabetes — oral weight loss formulations are in development and may offer lower cost alternatives to injectable versions.
Increased competition: Additional GLP-1 and related medications are in clinical trials — more options typically mean more competitive pricing.
Policy pressure: The political conversation around Medicare coverage of obesity medications is ongoing — potential policy changes could dramatically increase coverage access.
The Bottom Line
What weight loss injections actually cost:
| Option | Monthly Cost | Annual Cost |
|---|---|---|
| Brand name (no insurance) | $900-1,500 | $10,800-18,000 |
| Brand name (with good insurance) | $25-100 copay | $300-1,200 |
| Brand name + manufacturer savings card | $0-50 | $0-600 |
| Compounded (telehealth) | $150-400 | $1,800-4,800 |
| Patient assistance program | $0 | $0 |
The most practical options for most people:
- Check insurance — you might be covered, especially for diabetes indication
- Manufacturer savings card — if commercially insured, this can make brand name affordable
- Telehealth + compounded — the most accessible option for most people at $150-400/month
- Patient assistance — if income qualifies, medication may be free
The bottom line: brand name prices are real but not the only option. Most people who want access to these medications can find a pathway at $150-400/month through telehealth and compounded medication — a significant but potentially manageable cost for a medication that produces clinically meaningful weight loss.
What pathway have you used to access weight loss injections — and what would you tell others about navigating the cost? Share in the comments.
